Exclusive Video Q&A With Sijmen de Vries, CEO of Pharming Healthcare Global (press release) ... 2012) - Trading on the Euronext, Pharming Group NV (EURONEXT: PHARM) produces, purifies and formulates recombinant human proteins using its transgenic technology platform for therapeutic indications in Hereditary Angioedema, Transplant Rejection, ... |
